Back to Results
First PageMeta Content
Health / Pharmaceutical Benefits Scheme / Generic drug / Pharmaceutical industry / Prescription medication / Pfizer / Evergreening / Pharmaceutical drug / Pharmaceuticals policy / Pharmaceutical sciences / Pharmacology


March 2013 Australia’s  bad  drug  deal Grattan Institute Support Founding members
Add to Reading List

Document Date: 2014-08-04 20:26:57


Open Document

File Size: 856,32 KB

Share Result on Facebook

City

London / /

Company

Lend Lease / Program Affiliate Partners National Australia Bank Senior / Google / Senior Affiliates Wesfarmers Stockland GE Australia / Pfizer / Creative Commons / /

Country

Netherlands / Italy / Sweden / New Zealand / France / United States / Canada / Australia / United Kingdom / Finland / Spain / Ireland / /

Currency

AUD / USD / /

Facility

Australian Institute of Health / Grattan Institute / Young Grattan Institute / /

Holiday

Commonwealth Day of Australia / /

IndustryTerm

pharmaceutical pricing works / similar pharmaceuticals / confidential pharmaceutical price data / pharmaceutical / pharmaceutical prices / pharmaceuticals / pharmaceutical spending / pharmaceutical pricing / /

MedicalCondition

heart disease / /

Organization

Australian Government / OECD / Productivity Commission / New Zealand’s Pharmaceutical Management Agency / Grattan Institute Support Founding / office of Health Economics / Scanlon Foundation Ernst & Young Grattan Institute / African Union / Grattan Institute / Australian Institute of Health and Welfare / PHARMAC / Department of Health / /

Person

John Zalcberg / Leah Ginnivan / Jacqueline Cumming / Stephen Duckett / Sharon Willcox / Carol Bennett / Prasanna Venkataraman / Peter Breadon / Jeff Richardson / Philip Clarke / /

Position

Health Program Director with Peter Breadon / General / Professor / /

Product

Lipitor / /

PublishedMedium

Health Economics / /

RadioStation

5 When / /

URL

http /

SocialTag